OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effects of Fremanezumab on Psychiatric Comorbidities in Difficult-to-Treat Patients with Chronic Migraine: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry
Michail Vikelis, Emmanouil V. Dermitzakis, Georgia Xiromerisiou, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4526-4526
Open Access | Times Cited: 9
Michail Vikelis, Emmanouil V. Dermitzakis, Georgia Xiromerisiou, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4526-4526
Open Access | Times Cited: 9
Showing 9 citing articles:
Results of a Web-Based Survey on 2565 Greek Migraine Patients in 2023: Demographic Data, Imposed Burden and Satisfaction to Acute and Prophylactic Treatments in the Era of New Treatment Options
Emmanouil V. Dermitzakis, Andreas A. Argyriou, Konstantinos Bilias, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 10, pp. 2768-2768
Open Access | Times Cited: 4
Emmanouil V. Dermitzakis, Andreas A. Argyriou, Konstantinos Bilias, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 10, pp. 2768-2768
Open Access | Times Cited: 4
Global trends in migraine and anxiety over the past 10 years: a bibliometric analysis
Biao Huang, Weining Chen, Peng Chun-mei, et al.
Frontiers in Neurology (2025) Vol. 15
Open Access
Biao Huang, Weining Chen, Peng Chun-mei, et al.
Frontiers in Neurology (2025) Vol. 15
Open Access
Switching between anti-cgrp monoclonal antibodies in migraine prophylaxis
Michail Vikelis, Dimitrios Rikos, Andreas A. Argyriou, et al.
Expert Review of Neurotherapeutics (2025)
Closed Access
Michail Vikelis, Dimitrios Rikos, Andreas A. Argyriou, et al.
Expert Review of Neurotherapeutics (2025)
Closed Access
Nine-Month Continuous Fremanezumab Prophylaxis on the Response to Triptans and Also on the Incidence of Triggers, Hypersensitivity and Prodromal Symptoms of Patients with High-Frequency Episodic Migraine
Emmanouil V. Dermitzakis, Michail Vikelis, Georgia Xiromerisiou, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 386-386
Open Access | Times Cited: 3
Emmanouil V. Dermitzakis, Michail Vikelis, Georgia Xiromerisiou, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 386-386
Open Access | Times Cited: 3
Beyond Pain Relief: Unveiling the Multifaceted Impact of Anti-CGRP/R mAbs on Comorbid Symptoms in Resistant Migraine Patients
Alessandra Della Vecchia, Ciro De Luca, Lucrezia Becattini, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 677-677
Open Access | Times Cited: 3
Alessandra Della Vecchia, Ciro De Luca, Lucrezia Becattini, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 677-677
Open Access | Times Cited: 3
Can calcitonin gene‐related peptide monoclonal antibodies ameliorate writer's cramp and migraine?
Keisuke Suzuki, Shiho Suzuki, Hiroaki Fujita, et al.
Neuropsychopharmacology Reports (2024) Vol. 44, Iss. 2, pp. 482-484
Open Access | Times Cited: 1
Keisuke Suzuki, Shiho Suzuki, Hiroaki Fujita, et al.
Neuropsychopharmacology Reports (2024) Vol. 44, Iss. 2, pp. 482-484
Open Access | Times Cited: 1
Menopause and its impact on the effectiveness of fremanezumab for migraine prophylaxis: post-hoc analysis of a prospective, real-world Greek registry
Andreas A. Argyriou, Emmanouil V. Dermitzakis, Georgia Xiromerisiou, et al.
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 11, pp. 1119-1126
Closed Access
Andreas A. Argyriou, Emmanouil V. Dermitzakis, Georgia Xiromerisiou, et al.
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 11, pp. 1119-1126
Closed Access
Safety of Rimegepant in Adults with Migraine and Anxiety, Depression, or Using Antidepressants: Analysis of a Multicenter, Long-Term, Open-Label Study
David Kudrow, Susan Hutchinson, Glenn C. Pixton, et al.
Pain and Therapy (2024)
Open Access
David Kudrow, Susan Hutchinson, Glenn C. Pixton, et al.
Pain and Therapy (2024)
Open Access
Actualización sobre la comorbilidad migraña-depresión
Gustavo Adolfo Díaz Silva, Andrés Felipe Alzate-Arbeláez, María Isabel Valencia-Osorio, et al.
Acta neurológica colombiana (2023) Vol. 39, Iss. 4
Open Access
Gustavo Adolfo Díaz Silva, Andrés Felipe Alzate-Arbeláez, María Isabel Valencia-Osorio, et al.
Acta neurológica colombiana (2023) Vol. 39, Iss. 4
Open Access
